Latest Regulatory Compliance News

Advanced Health Intelligence has been formally delisted from NASDAQ due to shareholder equity deficiencies but is actively pursuing ASX reinstatement as a critical step toward regaining its dual-listing status.

INOVIQ Limited reports strong clinical validation for its EXO-OC ovarian cancer screening test and promising preclinical results for CAR-exosome therapeutics targeting aggressive cancers.

G8 Education faces ASX scrutiny over its handling of sensitive information about a former employee, with the regulator questioning the company’s disclosure practices despite GEM’s insistence of compliance.

Uvre Limited has completed its acquisition of promising New Zealand gold assets and appointed seasoned mining executives to its board, setting the stage for an accelerated exploration phase.

Bowen Coking Coal Limited (BCB) has responded to ASX inquiries about its liquidity challenges, working capital needs from transitioning to an owner-operator model, and deteriorating operating margins, affirming compliance and financial viability despite market pressures.

West Wits Mining appoints CEO Rudi Deysel as Managing Director and adds Keith Middleton as non-executive director, while veteran board member Hulme Scholes retires after 14 years. These changes come as the company transitions into operational gold production at its Qala Shallows project in South Africa.

Trigg Minerals has withdrawn previously reported mineral resource estimates for its Antimony Canyon Project after ASX compliance review, while reaffirming confidence in ongoing exploration efforts.

BMG Resources has addressed ASX concerns over the timing and disclosure of assay results from its Abercromby Gold Project drill program, confirming compliance with listing rules despite delays and data inconsistencies.

The Takeovers Panel has mandated Emu NL to hold a new shareholder meeting after finding serious irregularities in the recent extraordinary general meeting, including share issuance timing and proxy voting issues.

Invion Limited’s IVXO securities have been suspended from ASX quotation due to non-compliance with key listing rules, raising questions about the company’s regulatory standing and investor confidence.

AML3D Limited has confirmed it complied with ASX continuous disclosure rules regarding its recent Letter of Intent with the US Navy, clarifying the timing of its awareness and announcement.

Hydralyte USA has completed its Rights Issue by placing 5 million shortfall shares, raising a total of $608,878 before costs. The move finalizes the company’s recent capital raising efforts under full regulatory compliance.